Skip to content
Screener

Schrodinger SDGR Investing Cash Flow

Investing Cash Flow at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
-$2.11B-9,595%
Simulations Plus logo
Simulations PlusSLP
-$11.35M
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$1.96M+66.3%
Absci Corporation logo
Absci CorporationABSI
$24.07M
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$25.08M-416%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$353.03M-570%

Other financials

Income statement

See full
Revenue$58.9M+7.5%
Gross profit$32.4M+24.0%
Operating income-$41.5M+21.5%
Net income$6.0M+114%
EPS (diluted)$0.08+114%

Balance sheet

See full
Cash & equivalents$292.9M+26.3%
Total debt$108.0M-5.5%
Total equity$329.0M-4.1%
Total assets$640.4M-7.0%

Cash flow

See full
Operating cash flow-$34.1M
CapEx$362.0K+15.3%
Free cash flow-$34.4M

Valuation

See full
Market cap$1.36B+2.4%
Enterprise value$1.17B-2.7%
P/S5.2×-0.3×

Profitability

See full
Gross margin56.9%-1.6pp
Operating margin-59.2%-12.6pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.6×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Schrodinger’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001490978-26-000068
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Proceeds from disposition and sale of equity investments, net66,976
Purchases of marketable securities(103,992)(166,062)
Proceeds from maturity of marketable securities143,101142,003
Net cash provided by (used in) investing activities103,216(24,969)
Cash flows from financing activities:
Proceeds from issuances of common stock upon stock option exercises1,2482,456
Principal payments on finance leases(29)(29)
Net cash provided by financing activities1,2192,427

Item 1. Financial Statements.

FAQ

What is Schrodinger's investing cash flow?
Schrodinger (SDGR) reported investing cash flow of $58.62M in Q2 2026.
How has Schrodinger's investing cash flow changed year-over-year?
Schrodinger's investing cash flow increased by 205.4% year-over-year, from -$55.6M to $58.62M.
What is the long-term trend for Schrodinger's investing cash flow?
Over 2 years (2022 to 2025), Schrodinger's investing cash flow has grown at a -19.8% compound annual growth rate (CAGR), from $90.02M to $57.9M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Schrodinger's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude